FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378746596> ?p ?o ?g. }

• W4378746596 abstract "Background Chronic bleeding due to gastrointestinal (GI) involvement in patients with hemorrhagic hereditary telangiectasia (HHT) can provoke severe anemia with high red blood cells (RBC) transfusion requirements. However, the evidence about how to deal with these patients is scarce. We aimed to assess the long-term efficacy and safety of somatostatin analogs (SA) for anemia management in HHT patients with GI involvement. Methods This is a prospective observational study including patients with HHT and GI involvement attended at a referral center. SA were considered for those patients with chronic anemia. Anemia-related variables were compared in patients receiving SA before and during treatment. Patients receiving SA were divided into responders (patients with minimal hemoglobin levels improvement &gt;10 g/L and maintaining hemoglobin levels ≥80 g/L during treatment), and non-responders. Adverse effects during follow-up were collected. Results Among 119 HHT patients with GI involvement, 67 (56.3%) received SA. These patients showed lower minimal hemoglobin levels (73 [60–87] vs. 99 [70.2–122.5], p &lt; 0.001), and more RBC transfusion requirements (61.2% vs. 38.5%, p = 0.014) than patients without SA therapy. Median treatment period was 20.9 ± 15.2 months. During treatment, there was a statistically significant improvement in minimum hemoglobin levels (94.7 ± 29.8 g/L vs. 74.7 ± 19.7, p &lt; 0.001) and a reduction of patients with minimal hemoglobin levels &lt;80 g/L (39 vs. 61%, p = 0.007) and RBC transfusions requirement (33.9% vs. 59.3%, p &lt; 0.001). Sixteen (23.9%) patients showed mild adverse effects, mostly diarrhea or abdominal pain, leading to treatment discontinuation in 12 (17.9%) patients. Fifty-nine patients were eligible for efficacy assessment and 32 (54.2%) of them were considered responders. Age was associated with non-responder patients, OR 95% CI; 1.070 (1.014–1.130), p = 0.015. Conclusion SA can be considered a long-term effective and safe option for anemia management in HHT patients with GI bleeding. Older age is associated with poorer response." @default.
• W4378746596 created "2023-05-31" @default.
• W4378746596 creator A5010238262 @default.
• W4378746596 creator A5014812989 @default.
• W4378746596 creator A5018832695 @default.
• W4378746596 creator A5024842501 @default.
• W4378746596 creator A5029524574 @default.
• W4378746596 creator A5044360547 @default.
• W4378746596 creator A5048139879 @default.
• W4378746596 creator A5057078044 @default.
• W4378746596 creator A5057341718 @default.
• W4378746596 creator A5063828405 @default.
• W4378746596 creator A5069133933 @default.
• W4378746596 creator A5091189307 @default.
• W4378746596 date "2023-05-12" @default.
• W4378746596 modified "2023-10-13" @default.
• W4378746596 title "Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia" @default.
• W4378746596 cites W2016294573 @default.
• W4378746596 cites W2025255282 @default.
• W4378746596 cites W2025389410 @default.
• W4378746596 cites W2036541038 @default.
• W4378746596 cites W2046423604 @default.
• W4378746596 cites W2052927933 @default.
• W4378746596 cites W20590513 @default.
• W4378746596 cites W2059796825 @default.
• W4378746596 cites W2063789470 @default.
• W4378746596 cites W2066373902 @default.
• W4378746596 cites W2067658227 @default.
• W4378746596 cites W2075249851 @default.
• W4378746596 cites W2080299984 @default.
• W4378746596 cites W2083332894 @default.
• W4378746596 cites W2126935484 @default.
• W4378746596 cites W2131246162 @default.
• W4378746596 cites W2143723459 @default.
• W4378746596 cites W2150580148 @default.
• W4378746596 cites W2152806804 @default.
• W4378746596 cites W2170187605 @default.
• W4378746596 cites W2177426201 @default.
• W4378746596 cites W2747814331 @default.
• W4378746596 cites W2753996507 @default.
• W4378746596 cites W2784662763 @default.
• W4378746596 cites W2887374555 @default.
• W4378746596 cites W2898254054 @default.
• W4378746596 cites W2902191996 @default.
• W4378746596 cites W2911223821 @default.
• W4378746596 cites W2918061115 @default.
• W4378746596 cites W2919881019 @default.
• W4378746596 cites W2955112295 @default.
• W4378746596 cites W2984083336 @default.
• W4378746596 cites W2998339954 @default.
• W4378746596 cites W3043395065 @default.
• W4378746596 cites W3199800051 @default.
• W4378746596 cites W37187123 @default.
• W4378746596 cites W4234343739 @default.
• W4378746596 cites W4293729582 @default.
• W4378746596 doi "https://doi.org/10.3389/fmed.2023.1146080" @default.
• W4378746596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37250655" @default.
• W4378746596 hasPublicationYear "2023" @default.
• W4378746596 type Work @default.
• W4378746596 citedByCount "1" @default.
• W4378746596 countsByYear W43787465962023 @default.
• W4378746596 crossrefType "journal-article" @default.
• W4378746596 hasAuthorship W4378746596A5010238262 @default.
• W4378746596 hasAuthorship W4378746596A5014812989 @default.
• W4378746596 hasAuthorship W4378746596A5018832695 @default.
• W4378746596 hasAuthorship W4378746596A5024842501 @default.
• W4378746596 hasAuthorship W4378746596A5029524574 @default.
• W4378746596 hasAuthorship W4378746596A5044360547 @default.
• W4378746596 hasAuthorship W4378746596A5048139879 @default.
• W4378746596 hasAuthorship W4378746596A5057078044 @default.
• W4378746596 hasAuthorship W4378746596A5057341718 @default.
• W4378746596 hasAuthorship W4378746596A5063828405 @default.
• W4378746596 hasAuthorship W4378746596A5069133933 @default.
• W4378746596 hasAuthorship W4378746596A5091189307 @default.
• W4378746596 hasBestOaLocation W43787465961 @default.
• W4378746596 hasConcept C126322002 @default.
• W4378746596 hasConcept C141071460 @default.
• W4378746596 hasConcept C197934379 @default.
• W4378746596 hasConcept C2776297358 @default.
• W4378746596 hasConcept C2776330896 @default.
• W4378746596 hasConcept C2778080469 @default.
• W4378746596 hasConcept C2778248108 @default.
• W4378746596 hasConcept C2778917026 @default.
• W4378746596 hasConcept C2780014101 @default.
• W4378746596 hasConcept C71924100 @default.
• W4378746596 hasConcept C90924648 @default.
• W4378746596 hasConceptScore W4378746596C126322002 @default.
• W4378746596 hasConceptScore W4378746596C141071460 @default.
• W4378746596 hasConceptScore W4378746596C197934379 @default.
• W4378746596 hasConceptScore W4378746596C2776297358 @default.
• W4378746596 hasConceptScore W4378746596C2776330896 @default.
• W4378746596 hasConceptScore W4378746596C2778080469 @default.
• W4378746596 hasConceptScore W4378746596C2778248108 @default.
• W4378746596 hasConceptScore W4378746596C2778917026 @default.
• W4378746596 hasConceptScore W4378746596C2780014101 @default.
• W4378746596 hasConceptScore W4378746596C71924100 @default.
• W4378746596 hasConceptScore W4378746596C90924648 @default.
• W4378746596 hasLocation W43787465961 @default.
• W4378746596 hasLocation W43787465962 @default.
• W4378746596 hasOpenAccess W4378746596 @default.

• next